ejournals

Informacje

Afiliacja

Zakład Ekonomiki Zdrowia i Zabezpieczenia Społecznego, Instytut Zdrowia Publicznego, Wydział Nauk o Zdrowiu, Uniwersytet Jagielloński Collegium Medicum, Kraków, Wojewódzka Stacja Sanitarno–Epidemiologiczna w Krakowie, ul. Prądnicka 76, Kraków

Wojewódzka Stacja Sanitarno–Epidemiologiczna w Krakowie, ul. Prądnicka 76, Kraków

Artykuły

Sortowanie:

Autor

Finansowanie najdroższych terapii lekowych w Polsce a problemy w dostępie do nich. Analiza poziomu finansowania i opłacalności programów terapeutycznych

Michał Seweryn

Zdrowie Publiczne i Zarządzanie, Tom 9, Numer 2, 2011, s. 97 - 104

https://doi.org/10.4467/20842627OZ.11.021.0558

Financing of the most expensive drug therapies in Poland. Analysis of the funding level of the therapeutic health programs

One of the most discussed topics about organization of the Polish health care system is providing full accessibility to the financing of the latest drug therapies. According to the institutions implementing the programs most serious causes of problems in access to innovative pharmacotherapy are too low level of funding programs and their low profitability, or even hospitals pay the extra to such benefits. Due to the increasingly high cost of treatment of severe illnesses and ongoing development of new medical technologies, in choosing the method of treatment are taken into account the results of economic analyzes.
The authors, by analyzing the level of funding and implementation of treatment programs, have attempted to answer the question whether the claims are true, and health care providers and Polish patients have equal access to the most expensive drug therapies? To verify the above hypothesis also performed an cost analysis of selected therapeutic programs. Cost analysis conducted based on the identification and analysis of the costs of four therapeutic health programs indicated that the refund value of National Health Fund for providers implementing health programs may be substantially higher than the costs incurred by them.
The current way of financing most expensive innovation therapy has many weaknesses, but most frequently mentioned causes of the problems with the availability of treatment programs are not supported by actual data.

PDF

Czytaj więcej

Autor

Funkcjonowanie Państwowej Inspekcji Sanitarnej. Historia, rozwój, wyzwania

Michał Seweryn

Zdrowie Publiczne i Zarządzanie, Tom 13 Numer 2, 2015, s. 158 - 164

https://doi.org/10.4467/20842627OZ.15.016.4319

The State Sanitary Inspection was founded in 1954 to protect human health and life against adverse environmental factors and to prevent communicable, occupational and other types of diseases.

Currently, following Poland’s State Sanitary Inspection still has important role to play in public health system. The State Sanitary Inspection needs to address actively and effectively all public health issues to society.

This article presents the changes in structure and tasks of this institution. The legal background of the above changes is also analysed. Key point of discussion is also impact of new Public Health Act to the role of Sanitary Inspection in Polish Health care system.

PDF

Czytaj więcej

Autor

Ogniska zakażeń szpitalnych w województwie małopolskim w latach 2011-2013

Michał Seweryn

Zdrowie Publiczne i Zarządzanie, Tom 12 Numer 2, 2014, s. 175 - 182

https://doi.org/10.4467/20842627OZ.14.019.3111

Despite the continuous advances of medicine and higher safety standards for patients, nosocomial infections are a major problem accompanying of treatment process. Infected patients are exposed to prolonged hospital stay, require additional medical procedures, theresofore their treatment and care are associated with additional costs for health facility. In the present study the number of outbreaks of nosocomial infections, which occurred in hospitals in the Malopolska province and in Poland, as well as etiological factors of the infections in the years 2011–2013 were analyzed. In the analyzed period we observed increase in the number of outbreaks of infections in Poland and in Malopolska (from 339 to 394 and from 19 to 26 in Poland and Malopolska respectively). The most frequently identified factor is C. difficile and Rotavirus, followed by K. pneumoniae ESBL, and Norovirus. There was a decrease in the number of outbreaks of unknown etiology, both in Poland and in Malopolska. The analysis identified an increase in the number of outbreaks caused by C. difficile, Noroviruses and Rotaviruses, as the main problem in the recent years. This trend occurs in the Malopolska region and in the country. However, the analysis of the reports shows improved reportability of outbreaks in Malopolska and in Poland which will allow for better control of nosocomial infections.

PDF

Czytaj więcej

Autor

Rola oceny ekonomicznej w podejmowaniu decyzji o finansowaniu innowacyjnych procedur medycznych

Michał Seweryn

Zdrowie Publiczne i Zarządzanie, Tom 8, Numer 2, 2010, s. 57 - 72

Role of Economic Evaluation in Decision-Making of Innovative Health Technologies

The aim of this article is to show the general possibility of application of chosen economic evaluation to assess innovative health technologies. The focus will be on the advantages related to use of HTA in decision making. It seems that the most important consequence of using economic evaluation is an opportunity to direct comparisons of the cost effectiveness and health benefits generated by innovative technologies which are financed from public sources.

PDF

Czytaj więcej